Abstract
Atherosclerosis (AS) is a chronic inflammatory disease characterized by abnormal lipid metabolism. Foam cell formation is also known as an early event of AS. Cholesterol efflux is a process whereby cholesterol is excreted from foam cells through transporters, which serves as one of the effective regulatory mechanisms to prevent AS. Autophagy is a biodegradable mechanism, and lipophagy is a special form of autophagy that selectively degrades lipids. Cholesterol efflux is regulated by several mechanisms. Moreover, numerous studies have shown that autophagy is also process whereby cholesterol efflux is regulated. In early studies, scholars found that cholesterol efflux is related to autophagy. Subsequent studies have shown that various targeted molecules can induce autophagy and promote the expression of cholesterol transporters (such as LXRα, ABCA1, and ABCG1) through specific signaling pathways. Several novel treatments for AS use these small molecules as entry points for research and development based on autophagy. However, this autophagy-dependent cholesterol efflux involves many different molecular mechanisms. This not only indicates that cholesterol efflux is the result of multiple factors, but also that autophagy, which mediates cholesterol efflux, is a complex physiological mechanism. Through a literature review, we found that the role of autophagy in cholesterol efflux is related to cell type and is regulated by both the level of autophagy and the mechanism that triggers autophagy. In this review, we aim to discuss the role of autophagy in cholesterol efflux from many aspects based on recent relevant studies to aid in the treatment of AS.
Similar content being viewed by others
References
Amengual J, Guo L, Strong A, Madrigal-Matute J, Wang H, Kaushik S et al (2018) Autophagy is required for sortilin-mediated degradation of apolipoprotein B100. Circ Res 122:568–582. https://doi.org/10.1161/CIRCRESAHA.117.311240
Avart SJ, Bernard DW, Jerome WG, Glick JM (1999) Cholesteryl ester hydrolysis in J774 macrophages occurs in the cytoplasm and lysosomes. J Lipid Res 40:405–414. https://doi.org/10.1016/S0022-2275(20)32444-5
Bi X, Vitali C, Cuchel M (2015) ABCA1 and inflammation. Arterioscler Thromb Vasc Biol 35:1551–1553. https://doi.org/10.1161/ATVBAHA.115.305547
Blom DJ, Raal FJ, Santos RD, Marais AD (2019) Lomitapide and mipomersen—inhibiting microsomal triglyceride transfer protein (MTP) and apoB100 synthesis. Curr Atheroscler Rep 21:48. https://doi.org/10.1007/s11883-019-0809-3
Brichkina A, Bulavin DV (2014) WIP-ing out atherosclerosis with autophagy. Autophagy 8:1545–1547. https://doi.org/10.4161/auto.21402
Brownell N, Rohatgi A (2016) Modulating cholesterol efflux capacity to improve cardiovascular disease. Curr Opin Lipidol 27:398–407. https://doi.org/10.1097/MOL.0000000000000317
Castella B, Kopecka J, Sciancalepore P, Mandili G, Foglietta M, Mitro N et al (2017) The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells. Nat Commun 8:15663. https://doi.org/10.1038/ncomms15663
Chandra A, Rick J, Yagnik G, Aghi MK (2019) Autophagy as a mechanism for anti-angiogenic therapy resistance. Semin Cancer Biol 66:75–88. https://doi.org/10.1016/j.semcancer.2019.08.031
Diao Y (2021) Clematichinenoside AR alleviates foam cell formation and the inflammatory response in Ox-LDL-induced RAW264.7 cells by activating autophagy. Inflammation 44:758–768. https://doi.org/10.1007/s10753-020-01375-x
Dong F, Mo Z, Eid W, Courtney KC, Zha X (2014) Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1. PLoS ONE 9:e113789. https://doi.org/10.1371/journal.pone.0113789
Feng X, Yuan Y, Wang C, Feng J, Yuan Z, Zhang X et al (2014) Autophagy involved in lipopolysaccharide-induced foam cell formation is mediated by adipose differentiation-related protein. Lipids Health Dis 13:10. https://doi.org/10.1186/1476-511X-13-10
Fournier N, Travers S, Passet M, Sserve P, Girard E, Vedie B et al (2014) Autophagy is not required for abca1-mediated cholesterol efflux in cholesterol loaded human monocyte-derived macrophages. Atherosclerosis 235:e182. https://doi.org/10.1016/j.atherosclerosis.2014.05.531
Frambach SJCM, de Haas R, Smeitink JAM, Rongen GA, Russel FGM, Schirris TJJ (2019) Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment. Pharmacol Rev 72:152–190. https://doi.org/10.1124/pr.119.017897
Gao F, Li G, Liu C, Gao H, Wang H, Liu W et al (2018) Autophagy regulates testosterone synthesis by facilitating cholesterol uptake in Leydig cells. J Cell Biol 217:2103–2119. https://doi.org/10.1083/jcb.201710078
Geldenhuys WJ, Lin L, Darvesh AS, Sadana P (2017) Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases. Drug Discov Today 22:352–365. https://doi.org/10.1016/j.drudis.2016.10.007
Georgila K, Gounis M, Havaki S, Gorgoulis VG, Eliopoulos AG (2020) mTORC1-dependent protein synthesis and autophagy uncouple in the regulation of apolipoprotein A-I expression. Metabolism 105:154186. https://doi.org/10.1016/j.metabol.2020.154186
Gu H, Li H, Tang Y, Tang X, Zheng X, Liao D (2016) Nicotinate-curcumin impedes foam cell formation from THP-1 cells through restoring autophagy flux. PLoS ONE 11:e154820. https://doi.org/10.1371/journal.pone.0154820
Hafiane A, Favari E, Daskalopoulou SS, Vuilleumier N, Frias MA (2020) High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases. Metabolism 104:154141. https://doi.org/10.1016/j.metabol.2020.154141
Han XB, Li HX, Jiang YQ, Wang H, Li XS, Kou JY et al (2017) Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation. Cell Death Dis 8:e2864. https://doi.org/10.1038/cddis.2017.242
He J, Zhang G, Pang Q, Yu C, Xiong J, Zhu J et al (2017) SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox-LDL condition. FEBS J 284:1324–1337. https://doi.org/10.1111/febs.14055
Huang B, Jin M, Yan H, Cheng Y, Huang D, Ying S et al (2014) Simvastatin enhances oxidized-low density lipoprotein-induced macrophage autophagy and attenuates lipid aggregation. Mol Med Rep 11:1093–1098. https://doi.org/10.3892/mmr.2014.2790
Huang C, Yu X, Zheng X, Ou X, Tang C (2018) Interferon-stimulated gene 15 promotes cholesterol efflux by activating autophagy via the miR-17-5p/Beclin-1 pathway in THP-1 macrophage-derived foam cells. Eur J Pharmacol 827:13–21. https://doi.org/10.1016/j.ejphar.2018.02.042
Jamuna S, Ashokkumar R, Sakeena Sadullah MS, Devaraj SN (2019) Oligomeric proanthocyanidins and epigallocatechin gallate aggravate autophagy of foam cells through the activation of class III PI3K/Beclin1-complex mediated cholesterol efflux. BioFactors 45:763–773. https://doi.org/10.1002/biof.1537
Jeong S, Kim S, Park J, Jung I, Lee M, Jeon S et al (2018) Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy 14:120–133. https://doi.org/10.1080/15548627.2017.1327942
Jiang Q, Hao R, Wang W, Gao H, Wang C (2016) SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid. Mol Cell Biochem 420:171–184. https://doi.org/10.1007/s11010-016-2787-x
Jiang Y, Yang G, Liao Q, Zou Y, Du Y, Huang J (2019) Indole-3-carbinol inhibits lipid deposition and promotes autophagy in hyperlipidemia zebrafish larvae. Environ Toxicol Phar 70:103205. https://doi.org/10.1016/j.etap.2019.103205
Kaushik S, Cuervo AM (2015) Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis. Nat Cell Biol 17:759–770. https://doi.org/10.1038/ncb3166
Kim YC, Guan K (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125:25–32. https://doi.org/10.1172/JCI73939
Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445–544. https://doi.org/10.4161/auto.19496
Kobiyama K, Ley K (2018) Atherosclerosis a chronic inflammatory disease with an autoimmune component. Circ Res 123:1118–1120. https://doi.org/10.1161/CIRCRESAHA.118.313816
Kou JY, Li Y, Zhong ZY, Jiang YQ, Li XS, Han XB et al (2018) Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage. Cell Death Dis 8:e2558. https://doi.org/10.1038/cddis.2016.354
Kounakis K, Chaniotakis M, Markaki M, Tavernarakis N (2019) Emerging roles of lipophagy in health and disease. Front Cell Dev Biol 7:185. https://doi.org/10.3389/fcell.2019.00185
Lavandero S, Chiong M, Rothermel BA, Hill JA (2015) Autophagy in cardiovascular biology. J Clin Invest 125:55–64. https://doi.org/10.1172/JCI73943
Le Guezennec X, Brichkina A, Huang Y, Kostromina E, Han W, Bulavin DV (2012) Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab 16:68–80. https://doi.org/10.1016/j.cmet.2012.06.003
Leng S, Iwanowycz S, Saaoud F, Wang J, Wang Y, Sergin I et al (2016) Ursolic acid enhances macrophage autophagy and attenuates atherogenesis. J Lipid Res 57:1006–1016. https://doi.org/10.1194/jlr.M065888
Li B, Liao S, Yin Y, Long C, Guo L, Cao X et al (2015) Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy. Mol Biol Rep 42:179–186. https://doi.org/10.1007/s11033-014-3757-6
Li X, Zhang X, Zheng L, Kou J, Zhong Z, Jiang Y et al (2016) Hypericin-mediated sonodynamic therapy induces autophagy and decreases lipids in THP-1 macrophage by promoting ROS-dependent nuclear translocation of TFEB. Cell Death Dis 7:e2527. https://doi.org/10.1038/cddis.2016.433
Li X, Zhou Y, Zhang X, Cao X, Wu C, Guo P (2017) Cordycepin stimulates autophagy in macrophages and prevents atherosclerotic plaque formation in ApoE-/- mice. Oncotarget 8:94726–37. https://doi.org/10.18632/oncotarget.21886
Li C, Ye L, Yang L, Yu X, He Y, Chen Z et al (2018) Rapamycin promotes the survival and adipogenesis of ischemia-challenged adipose derived stem cells by improving autophagy. Cell Physiol Biochem 44:1762–1774. https://doi.org/10.1159/000485783
Li Y, Sun T, Shen S, Wang L, Yan J (2019) LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy. Biol Chem 400:1047–1057. https://doi.org/10.1515/hsz-2018-0461
Liang X, Guan X (2017) p62/SQSTM1: A potential molecular target for treatment of atherosclerosis. Front Lab Med 1:104–106. https://doi.org/10.1016/j.flm.2017.06.007
Liang X, Wang C, Sun Y, Song W, Lin J, Li J et al (2019) p62/mTOR/LXRα pathway inhibits cholesterol efflux mediated by ABCA1 and ABCG1 during autophagy blockage. Biochem Bioph Res Co 514:1093–1100. https://doi.org/10.1016/j.bbrc.2019.04.134
Liang X, Liu L, Wang Y, Guo H, Fan H, Zhang C et al (2020) Autophagy-driven NETosis is a double-edged sword – review. Biomed Pharmacother 126:110065. https://doi.org/10.1016/j.biopha.2020.110065
Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P et al (2018) A review on central nervous system effects of gastrodin. Front Pharmacol 9:24. https://doi.org/10.3389/fphar.2018.00024
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:2095–2128. https://doi.org/10.1016/S0140-6736(12)61728-0
Lu R, Tsuboi T, Okumura-Noji K, Iwamoto N, Yokoyama S (2016) Caveolin-1 facilitates internalization and degradation of ABCA1 and probucol oxidative products interfere with this reaction to increase HDL biogenesis. Atherosclerosis 253:54–60. https://doi.org/10.1016/j.atherosclerosis.2016.08.025
Lu S, Luo Y, Sun G, Sun X (2020) Ginsenoside compound K attenuates Ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-κB, p38, and JNK MAPK signaling. Front Pharmacol 11:567238. https://doi.org/10.3389/fphar.2020.567238
Luo F, Das A, Chen J, Wu P, Li X, Fang Z (2019) Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management. Cardiovasc Diabetol 18:54. https://doi.org/10.1186/s12933-019-0860-y
Ma Y, Huang Z, Zhou Z, He X, Wang Y, Meng C et al (2018) A novel antioxidant Mito-Tempol inhibits ox-LDL-induced foam cell formation through restoration of autophagy flux. Free Radical Bio Med 129:463–472. https://doi.org/10.1016/j.freeradbiomed.2018.10.412
Ma C, Zhang W, Yang X, Liu Y, Liu L, Feng K et al (2018) Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice − a new anti-atherogenic strategy. Brit J Pharmacol 175:1486–1503. https://doi.org/10.1111/bph.14156
Madeo F, Eisenberg T, Büttner S, Ruckenstuhl C, Kroemer G (2014) Spermidine: a novel autophagy inducer and longevity elixir. Autophagy 6:160–162. https://doi.org/10.4161/auto.6.1.10600
Martinez-Lopez N, Garcia-Macia M, Sahu S, Athonvarangkul D, Liebling E, Merlo P et al (2016) Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the brown adipose tissue and liver. Cell Metab 23:113–127. https://doi.org/10.1016/j.cmet.2015.10.008
Michiels CF, Kurdi A, Timmermans J, De Meyer GRY, Martinet W (2016) Spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy. Atherosclerosis 251:319–327. https://doi.org/10.1016/j.atherosclerosis.2016.07.899
Nnah IC, Wang B, Saqcena C, Weber GF, Bonder EM, Bagley D et al (2019) TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy. Autophagy 15:151–164. https://doi.org/10.1080/15548627.2018.1511504
Ouimet M, Marcel YL (2012) Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 32:575–581. https://doi.org/10.1161/ATVBAHA.111.240705
Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL (2011) Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 13:655–667. https://doi.org/10.1016/j.cmet.2011.03.023
Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X et al (2017) microRNA-33 regulates macrophage autophagy in atherosclerosis. Arterioscler Thromb Vasc Biol 37:1058–1067. https://doi.org/10.1161/ATVBAHA.116.308916
Ouimet M, Barrett TJ, Fisher EA (2019) HDL and reverse cholesterol transport. Circ Res 124:1505–1518. https://doi.org/10.1161/CIRCRESAHA.119.312617
Phillips MC (2014) Molecular mechanisms of cellular cholesterol efflux. J Biol Chem 289:24020–24029. https://doi.org/10.1074/jbc.R114.583658
Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X et al (2021) The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy 17:980–1000. https://doi.org/10.1080/15548627.2020.1741202
Pietrocola F, Lachkar S, Enot DP, Niso-Santano M, Bravo-San Pedro JM, Sica V et al (2015) Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death Differ 22:509–516. https://doi.org/10.1038/cdd.2014.215
Qiao L, Wang H, Xiang L, Ma J, Zhu Q, Xu D et al (2020) Deficient chaperone-mediated autophagy promotes lipid accumulation in macrophage. J Cardiovasc Transl. https://doi.org/10.1007/s12265-020-09986-3
Rao X, Wang Y (2019) Apolipoprotein A-I improves hepatic autophagy through the AMPK pathway. Biochimie 165:210–218. https://doi.org/10.1016/j.biochi.2019.08.001
Ren H, Wang D, Zhang L, Kang X, Li Y, Zhou X et al (2019) Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. Aging 11:9461–9477. https://doi.org/10.18632/aging.102396
Robichaud S, Fairman G, Vijithakumar V, Mak E, Cook DP, Pelletier AR et al (2021) Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells. Autophagy 17:3671–3689. https://doi.org/10.1080/15548627.2021.1886839
Robinet P, Ritchey B, Smith JD (2013) Physiological difference in autophagic flux in macrophages from 2 mouse strains regulates cholesterol ester metabolism. Arterioscler Thromb Vasc Biol 33:903–910. https://doi.org/10.1161/ATVBAHA.112.301041
Rohatgi A (2019) Reverse cholesterol transport and atherosclerosis. Arterioscler Thromb Vasc Biol 39:2–04. https://doi.org/10.1161/ATVBAHA.118.311978
Ronsein GE, Vaisar T (2017) Inflammation, remodeling, and other factors affecting HDL cholesterol efflux. Curr Opin Lipidol 1:52–59. https://doi.org/10.1097/MOL.0000000000000382
Röszer T (2017) Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors. Apoptosis 22:284–294. https://doi.org/10.1007/s10495-016-1310-x
Saliba Gustafsson P, Pedrelli M, Gertow K, Werngren O, Janas V, Pourteymour S et al (2019) Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy. J Intern Med 286:660–675. https://doi.org/10.1111/joim.12951
Shao B, Han B, Zeng Y, Su D, Liu C (2016) The roles of macrophage autophagy in atherosclerosis. Acta Pharmacol Sin 37:150–156. https://doi.org/10.1038/aps.2015.87
Sharma L, Lone NA, Knott RM, Hassan A, Abdullah T (2018) Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. Food Chem Toxicol 121:283–296. https://doi.org/10.1016/j.fct.2018.09.011
Shen W, Azhar S, Kraemer FB (2018) SR-B1: a unique multifunctional receptor for cholesterol influx and efflux. Annu Rev Physiol 80:95–116. https://doi.org/10.1146/annurev-physiol-021317-121550
Shi X, Li W, Liu H, Yin D, Zhao J (2017) β-Cyclodextrin induces the differentiation of resident cardiac stem cells to cardiomyocytes through autophagy. Biochim Biophys Acta Molec Cell Res 1864:1425–34. https://doi.org/10.1016/j.bbamcr.2017.05.012
Shi Y, Jia M, Xu L, Fang Z, Wu W, Zhang Q et al (2019) miR-96 and autophagy are involved in the beneficial effect of grape seed proanthocyanidins against high-fat-diet-induced dyslipidemia in mice. Phytother Res 33:1222–1232. https://doi.org/10.1002/ptr.6318
Shi Y, Jiang S, Zhao T, Gong Y, Liao D, Qin L (2020) Celastrol suppresses lipid accumulation through LXRα/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells. Biochem Bioph Res Co 532:466–474. https://doi.org/10.1016/j.bbrc.2020.08.076
Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M et al (2009) Autophagy regulates lipid metabolism. Nature 458:1131–1135. https://doi.org/10.1038/nature07976
Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK et al (2009) Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 119:3329–3339. https://doi.org/10.1172/JCI39228
Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y et al (2020) Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health 8:e721–e729. https://doi.org/10.1016/S2214-109X(20)30117-0
Sukhorukov VN, Khotina VA, Chegodaev YS, Ivanova E, Sobenin IA, Orekhov AN (2020) Lipid metabolism in macrophages: focus on atherosclerosis. Biomedicines 8:262. https://doi.org/10.3390/biomedicines8080262
Tabas I, García-Cardeña G, Owens GK (2015) Recent insights into the cellular biology of atherosclerosis. J Cell Biol 209:13–22. https://doi.org/10.1083/jcb.201412052
Talbot CPJ, Plat J, Ritsch A, Mensink RP (2018) Determinants of cholesterol efflux capacity in humans. Prog Lipid Res 69:21–32. https://doi.org/10.1016/j.plipres.2017.12.001
Tang Y, Wu H, Shao B, Wang Y, Liu C, Guo M (2018) Celosins inhibit atherosclerosis in ApoE-/- mice and promote autophagy flow. J Ethnopharmacol 215:74–82. https://doi.org/10.1016/j.jep.2017.12.031
Tao J, Yang P, Xie L, Pu Y, Guo J, Jiao J et al (2021) Gastrodin induces lysosomal biogenesis and autophagy to prevent the formation of foam cells via AMPK-FoxO1-TFEB signalling axis. J Cell Mol Med 25:5769–5781. https://doi.org/10.1111/jcmm.16600
Texada MJ, Malita A, Christensen CF, Dall KB, Faergeman NJ, Nagy S et al (2019) Autophagy-mediated cholesterol trafficking controls steroid production. Dev Cell 48:659–671. https://doi.org/10.1016/j.devcel.2019.01.007
Vazquez MM, Gutierrez MV, Salvatore SR, Puiatti M, Dato VA, Chiabrando GA et al (2020) Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW264.7 macrophages. Redox Biol 36:101591. https://doi.org/10.1016/j.redox.2020.101591
Wang Y, Viscarra J, Kim S, Sul HS (2015) Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Bio 16:678–689. https://doi.org/10.1038/nrm4074
Wang L, Jiang Y, Song X, Guo C, Zhu F, Wang X et al (2016) Pdcd4 deficiency enhances macrophage lipoautophagy and attenuates foam cell formation and atherosclerosis in mice. Cell Death Dis 7:e2055. https://doi.org/10.1038/cddis.2015.416
Wang L, Palme V, Rotter S, Schilcher N, Cukaj M, Wang D et al (2017) Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages. Mol Nutr Food Res 61:1500960. https://doi.org/10.1002/mnfr.201500960
Wang HH, Garruti G, Liu M, Portincasa P, Wang DQH (2017) Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Ann Hepatol 16:S27-42. https://doi.org/10.5604/01.3001.0010.5495
Wang Y, Ding W, Li T (2018) Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Molec Cell Biol Lipids 1863:726–33. https://doi.org/10.1016/j.bbalip.2018.04.005
Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung A et al (2019) Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev 71:596–670. https://doi.org/10.1124/pr.118.017178
Wang C, Yang W, Liang X, Song W, Lin J, Sun Y et al (2020) MicroRNA-761 modulates foam cell formation and inflammation through autophagy in the progression of atherosclerosis. Mol Cell Biochem 474:135–146. https://doi.org/10.1007/s11010-020-03839-y
Ward C, Martinez-Lopez N, Otten EG, Carroll B, Maetzel D, Singh R et al (2016) Autophagy, lipophagy and lysosomal lipid storage disorders. Biochim Biophys Acta 1861:269–284. https://doi.org/10.1016/j.bbalip.2016.01.006
Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591
Wu W, Shan Z, Wang R, Chang G, Wang M, Wu R et al (2019) Overexpression of miR-223 inhibits foam cell formation by inducing autophagy in vascular smooth muscle cells. Am J Transl Res 11:4326–4336
Wu H, Feng K, Zhang C, Zhang H, Zhang J, Hua Y et al (2021) Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE-/- mice. Biochem Bioph Res Co 557:334–341. https://doi.org/10.1016/j.bbrc.2021.04.029
Xiaolong L, Dongmin G, Liu M, Zuo W, Huijun H, Qiufen T et al (2020) FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation. J Cell Mol Med 24:4992–5006. https://doi.org/10.1111/jcmm.15118
Xie Y, Li J, Kang R, Tang D (2020) Interplay between lipid metabolism and autophagy. Front Cell Dev Biol 8:431. https://doi.org/10.3389/fcell.2020.00431
Yang M, Silverstein RL (2019) CD36 signaling in vascular redox stress. Free Radical Bio Med 136:159–171. https://doi.org/10.1016/j.freeradbiomed.2019.02.021
Yang Y, Wang J, Guo S, Pourteymour S, Xu Q, Gong J et al (2020) Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS–AMPK–mTORC1–autophagy pathway. Redox Biol 32:101501. https://doi.org/10.1016/j.redox.2020.101501
Yao F, Lv Y, Zhang M, Xie W, Tan Y, Gong D et al (2015) Apelin-13 impedes foam cell formation by activating class III PI3K/Beclin-1-mediated autophagic pathway. Biochem Bioph Res Co 466:637–643. https://doi.org/10.1016/j.bbrc.2015.09.045
Younce C, Kolattukudy P (2012) MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 30:307–320. https://doi.org/10.1159/000339066
Yu X, Zhang D, Zheng X, Tang C (2019) Cholesterol transport system: an integrated cholesterol transport model involved in atherosclerosis. Prog Lipid Res 73:65–91. https://doi.org/10.1016/j.plipres.2018.12.002
Zahid MK, Rogowski M, Ponce C, Choudhury M, Moustaid-Moussa N, Rahman SM (2020) CCAAT/enhancer-binding protein beta (C/EBPβ) knockdown reduces inflammation, ER stress, and apoptosis, and promotes autophagy in oxLDL-treated RAW264.7 macrophage cells. Mol Cell Biochem 463:211–223. https://doi.org/10.1007/s11010-019-03642-4
Zhang L, Liu Q, Zhang H, Wang X, Chen S, Yang Y et al (2018) C1q/TNF-related protein 9 inhibits THP-1 macrophage foam cell formation by enhancing autophagy. J Cardiovasc Pharm 72:167–175. https://doi.org/10.1097/FJC.0000000000000612
Zhang C, Zhu N, Long J, Wu H, Wang Y, Liu B et al (2020) Celastrol induces lipophagy via the LXRα/ABCA1 pathway in clear cell renal cell carcinoma. Acta Pharmacol Sin 42:1472–1485. https://doi.org/10.1038/s41401-020-00572-6
Zhang J, Ma CR, Hua YQ et al (2021) Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy. Life Sci 276:118957. https://doi.org/10.1016/j.lfs.2020.118957
Zhang X, Qin Y, Wan X, Liu H, Lv C, Ruan W et al (2021) Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities. J Transl Med 19:62. https://doi.org/10.1186/s12967-021-02727-3
Zhang H, Ge S, Ni B, He K, Zhu P, Wu X et al (2021) Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages. Autophagy 17:4218–4230. https://doi.org/10.1080/15548627.2021.1909833
Zheng S, Du Y, Ye Q, Zha K, Feng J (2021) Atorvastatin enhances foam cell lipophagy and promotes cholesterol efflux through the AMP-activated protein kinase/mammalian target of rapamycin pathway. J Cardiovasc Pharm 77:508–518. https://doi.org/10.1097/FJC.0000000000000942
Zhou M, Ren P, Zhang Y, Li S, Li M, Li P et al (2019) Shen-Yuan-Dan capsule attenuates atherosclerosis and foam cell formation by enhancing autophagy and inhibiting the PI3K/Akt/mTORC1 signaling pathway. Front Pharmacol 10:603. https://doi.org/10.3389/fphar.2019.00603
Acknowledgements
The authors would like to thank Editage for technical editing of the manuscript.
Funding
This research was supported by the Nature Science Foundation of Heilongjiang Province (No. LH2020H137).
Author information
Authors and Affiliations
Contributions
Haipeng Guo: conceptualization; Dongmei Wei: writing—original draft; Rui Liu: writing—review and editing; Chao Zhang: drawing and tabulating; Song Jiang: searching literature; Weijia Wang: analyzing literature; Hongzhe Hu: software; Lijuan Shen: project administration; Xiaofei Liang: supervision, funding acquisition. The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Autophagy can regulate cholesterol efflux in foam cells by many molecular mechanisms.
• Autophagy-dependent cholesterol efflux may be related to autophagy level or autophagy mechanism.
• Autophagy-dependent cholesterol efflux is a potential therapeutic strategy for atherosclerosis.
Rights and permissions
About this article
Cite this article
Guo, H., Wei, D., Liu, R. et al. A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux. J Physiol Biochem 78, 557–572 (2022). https://doi.org/10.1007/s13105-021-00870-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-021-00870-5